Stock Rating Upgrade
Of late the Value Trend Rating for CVS Health Corp (NYSE: CVS) improved from C to B reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 11/10/23, CVS Health Corp (NYSE: CVS) stock increased 1.4%, closing at $67.68. The stock has performed in line with the market over the last nine months and has declined -2.8% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to exceed the cost of capital, CVS is expected to continue to be a major Value Builder.
CVS Health has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. With this rating, PTR's two proprietary measures of a stock's current attractiveness are providing inconsistent signals. CVS Health has a good Appreciation Score of 78 but a neutral Power Rating of 47, and the Positive Value Trend Rating results.